"The words were used in different contexts. We are very busy at this time and simply do not have time for these types of responses. Please refer to the press release and our previous response to you for explanation."

That is a poor answer in my opinion. They made an explicit statement about apabetalone disrupting this viral protein E and BRD2/4 interaction. Either Resverlogix made a mistake and made a bold statement that has not yet been experimentally proven (no data in the paper to show it), or at the time of the news release that was information Resverlogix knew about that was not public that informed their statement. It's one or the other. I don't buy their word play/context/too busy argument for one second.

BDAZ